52 related articles for article (PubMed ID: 9471247)
1. [Cell endocytosis of the complex interleukin-6-soluble interleukin-6 receptor and its intralysosomal degradation].
Korolenko TA; Heinrich PK; Hemmann U; Weiergraber O; Dittrich E; Graeve L
Biull Eksp Biol Med; 1997 Nov; 124(11):527-9. PubMed ID: 9471247
[No Abstract] [Full Text] [Related]
2. IL-6 transsignaling: the in vivo consequences.
Jones SA; Richards PJ; Scheller J; Rose-John S
J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
[TBL] [Abstract][Full Text] [Related]
3. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
[TBL] [Abstract][Full Text] [Related]
4. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor.
Ueda T; Tsuji K; Yoshino H; Ebihara Y; Yagasaki H; Hisakawa H; Mitsui T; Manabe A; Tanaka R; Kobayashi K; Ito M; Yasukawa K; Nakahata T
J Clin Invest; 2000 Apr; 105(7):1013-21. PubMed ID: 10749580
[TBL] [Abstract][Full Text] [Related]
5. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
6. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
[TBL] [Abstract][Full Text] [Related]
7. A combination of interleukin-6 and its soluble receptor impairs sperm motility: implications in infertility associated with endometriosis.
Yoshida S; Harada T; Iwabe T; Taniguchi F; Mitsunari M; Yamauchi N; Deura I; Horie S; Terakawa N
Hum Reprod; 2004 Aug; 19(8):1821-5. PubMed ID: 15166129
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the lysosome-associated membrane protein in a sucrose model of lysosomal storage.
Isaac EL; Karageorgos LE; Brooks DA; Hopwood JJ; Meikle PJ
Exp Cell Res; 2000 Feb; 254(2):204-9. PubMed ID: 10640418
[TBL] [Abstract][Full Text] [Related]
9. No inhibition of IL-27 signaling by soluble gp130.
Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
[TBL] [Abstract][Full Text] [Related]
10. Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.
Boulanger MJ; Chow DC; Brevnova EE; Garcia KC
Science; 2003 Jun; 300(5628):2101-4. PubMed ID: 12829785
[TBL] [Abstract][Full Text] [Related]
11. Coordination of interleukin-6 biology by membrane bound and soluble receptors.
Rose-John S
Adv Exp Med Biol; 2001; 495():145-51. PubMed ID: 11774558
[No Abstract] [Full Text] [Related]
12. [Interleukin-6 acts in different ways via soluble and membrane-bound receptors].
Igaz P; Tóth S; Madurka I; Falus A
Orv Hetil; 1998 Jul; 139(29):1741-4. PubMed ID: 9715090
[TBL] [Abstract][Full Text] [Related]
13. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
14. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
15. [Soluble IL-6 receptors].
Jabłońska E
Postepy Hig Med Dosw; 1998; 52(2):133-8. PubMed ID: 9640977
[TBL] [Abstract][Full Text] [Related]
16. Sorting soluble tumor necrosis factor (TNF) receptor for storage and regulated secretion in hematopoietic cells.
Gao Y; Hansson M; Calafat J; Tapper H; Olsson I
J Leukoc Biol; 2004 Oct; 76(4):876-85. PubMed ID: 15240756
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
[TBL] [Abstract][Full Text] [Related]
18. Increased myelinating capacity of embryonic stem cell derived oligodendrocyte precursors after treatment by interleukin-6/soluble interleukin-6 receptor fusion protein.
Zhang PL; Izrael M; Ainbinder E; Ben-Simchon L; Chebath J; Revel M
Mol Cell Neurosci; 2006 Mar; 31(3):387-98. PubMed ID: 16325417
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane.
Chow A; Toomre D; Garrett W; Mellman I
Nature; 2002 Aug; 418(6901):988-94. PubMed ID: 12198549
[TBL] [Abstract][Full Text] [Related]
20. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
